Novo Propharma Private Limited
About Novo Propharma Private Limited
Data last updated:
Novo Propharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the scientific research segment of the research and development sector. It was incorporated on 26 June 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2021PTC152575.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bagaiah Vooradi and Krishnaveni Vooradi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pno 18 Friends Col(Colony) H No 4 – 3/18 Puppalguda Ibrahimbagh Manikonda, Hyderabad, Telangana, India – 500089.
As per the financials filed for FY 2024, the company reported a revenue of ₹95.47 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net loss of ₹17,741 (net margin -0.2%) and EBITDA of -₹17,741 (EBITDA margin -0.2%).
Company details
Contact details
Novo Propharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPno 18 Friends Col(Colony) H No 4 – 3/18 Puppalguda Ibrahimbagh Manikonda, Hyderabad, Telangana, India – 500089
- IndustryResearch & Development, Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novo Propharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Novo Propharma Private Limited, buy the company report.
Financials of Novo Propharma Private Limited
FY 2025 filings availableNovo Propharma Private Limited reported revenue of ₹95.47 Lakh (down 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year. EBITDA fell 102% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹17,741 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹17,741 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -0.2% | ||
| Net Profit Margin | -0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Novo Propharma Private Limited, buy the company report.
Board of directors of Novo Propharma Private Limited
Novo Propharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bagaiah Vooradi | Director | 26 Jun 2021 | 5 Years 4 Months | Current |
| Krishnaveni Vooradi | Director | 26 Jun 2021 | 5 Years 4 Months | Current |
| Rajini Vooradi | Director | 26 Jun 2021 | 5 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Novo Propharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novo Propharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Novo Propharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Novo Propharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Bagaiah Vooradi was appointed as Director on 26 Jun 2021.
Frequently asked questions
Novo Propharma is an active private limited company based in Hyderabad, Telangana, India. The company works in science research, within the research and development industry. It was incorporated on 26 June 2021 (5+ years old) and is registered under CIN U73100TG2021PTC152575.
Novo Propharma has 3 current directors:
- Bagaiah Vooradi - Director
- Krishnaveni Vooradi - Director
- Rajini Vooradi - Director
The latest financial statements of Novo Propharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Novo Propharma is U73100TG2021PTC152575. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novo Propharma was incorporated on 26 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
Bagaiah Vooradi was appointed as Director on 26 Jun 2021. Krishnaveni Vooradi was appointed as Director on 26 Jun 2021. Rajini Vooradi was appointed as Director on 26 Jun 2021.
The registered office of Novo Propharma is at Pno 18 Friends ColColony H No 4 – 318 Puppalguda Ibrahimbagh Manikonda, Hyderabad, Telangana, India – 500089.
Novo Propharma operates in the research and development industry, in the science research segment.
Novo Propharma can be reached at its registered office: Pno 18 Friends ColColony H No 4 – 318 Puppalguda Ibrahimbagh Manikonda, Hyderabad, Telangana, India – 500089.
Novo Propharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
